Stock of Glen mark pharma is in uptrend & at Weekly BO level . Buying level above the 495 level for the target price of 540 level with the SL of 475. RSI is making +ve divergence. Also on daily chart stock is forming the rounding bottom pattern which is again the sign of bullish. so add the stock in your watch list to see the price action movement of the...
Glenmark is forming ascending channel pattern in 1D view, good stock for midterm .
Can expect a decent price hike in upcoming months & has potential to go up.
PS: this post is for educational purpose only! Remember stock market is Zero Sum Game! Trade @your own risk!
This is one of the better setups from the list of intraday stocks for tomorrow and so I wanted to share with you.
This is another of my price action strategy setup. Bandhan Bank gave almost 2% reward today, but I expect this setup to give around 1.5%-2% returns. I trade using a 5 min to take trades so I get better entry price. Levels are mentioned on the...
Glenmark Range Bound
A little upmove can be seen
in good market condition.
Resistance is around 439 while
Support is around 413.
If breakdown, we may see
level of 405-400 In near term.
Updated on : 20 July 2020 8.00am.
Disclaimer: Only for Learning Purpose.
Monthly chart -
Target 675 - 740
1. Price Volume breakout over trendline.
2. MACD positive cross over
3. RSI down trendline is broken on the upside.
4. RSI and William at favorable values supporting a BUY.
Glenmark , just as my previous posts had a bullish divergence in the monthly chart! We were bullish since April end! The wait for a breakout happened this month and after a retest, It was a confirmed buy! Check out the charts, check out my last posts on motherson, infy , Dr reddy! They all had a similar setup! Now Glenmark has broken the Downward channel and this...
With the strong recovery of the pharma sector, Glenmark is at the pre-virus levels and has been attempting to breakout of the range. The sector has been in consolidation for several days and it may attempt a breakout to slightly higher levels. The pharma sector may not face sell offs in the midst of the pandemic, in my opinion.